Cargando…

Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery

Detalles Bibliográficos
Autores principales:	Honoré, Bent, Rice, Gregory Edward, Vorum, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537915/ https://www.ncbi.nlm.nih.gov/pubmed/34681691 http://dx.doi.org/10.3390/ijms222011031

Ejemplares similares

Identification of differentially regulated proteins in a patient with Leber's Congenital Amaurosis – a proteomic study
por: Vorum, Henrik, et al.
Publicado: (2007)

A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2017)

Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
por: Ludvigsen, Maja, et al.
Publicado: (2021)

Attempting to distinguish between endogenous and contaminating cytokeratins in a corneal proteomic study
por: Lyngholm, Mikkel, et al.
Publicado: (2011)

Ocular Proteomics with Emphasis on Two-Dimensional Gel Electrophoresis and Mass Spectrometry
por: Mandal, Nakul, et al.
Publicado: (2009)

Proteomic Analysis of Tissue from α1,3-galactosyltransferase Knockout Mice Reveals That a Wide Variety of Proteins and Protein Fragments Change Expression Level
por: Thorlacius-Ussing, Louise, et al.
Publicado: (2013)

Dye-Free Porcine Model of Experimental Branch Retinal Vein Occlusion: A Suitable Approach for Retinal Proteomics
por: Jørgensen Cehofski, Lasse, et al.
Publicado: (2015)

Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer
por: Ludvigsen, Maja, et al.
Publicado: (2020)

Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2023)

Proteomic Analysis of the Vitreous following Experimental Retinal Detachment in Rabbits
por: Mandal, Nakul, et al.
Publicado: (2015)

Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2020)

Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
por: Liu, Wei, et al.
Publicado: (2022)

Proteomics as a Tool for Biomarker Discovery
por: Kohn, Elise C., et al.
Publicado: (2007)

Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity
por: Ludvigsen, Maja, et al.
Publicado: (2009)

Ca(2+ )binding to complement-type repeat domains 5 and 6 from the low-density lipoprotein receptor-related protein
por: Andersen, Olav M, et al.
Publicado: (2003)

Animal Models Used to Simulate Retinal Artery Occlusion: A Comprehensive Review
por: Vestergaard, Nanna, et al.
Publicado: (2019)

Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)

The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery
por: Savino, Rocco, et al.
Publicado: (2012)

Proteomics Approaches for Biomarker and Drug Target Discovery in ALS and FTD
por: Hedl, Thomas J., et al.
Publicado: (2019)

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
por: Belbin, Olivia, et al.
Publicado: (2020)

Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm
por: Urbonavicius, Sigitas, et al.
Publicado: (2005)

Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion
por: Cehofski, Lasse Jørgensen, et al.
Publicado: (2022)

Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers
por: Lazar, Jozsef, et al.
Publicado: (2023)

Protein-Targeting Drug Discovery
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Rediscovering the Drug Discovery with Natural Products as Therapeutic Tools
por: Kumar, Arun H. S.
Publicado: (2018)

Discovery, Design, Synthesis, and Application of Nucleoside/Nucleotides
por: Seley-Radtke, Katherine
Publicado: (2020)

Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022)

Drug Discovery Targeting COVID-19
por: Spicer, Timothy P.
Publicado: (2020)

Proteomics of Uveal Melanoma: A Minireview
por: Abildgaard, Søren K. O., et al.
Publicado: (2013)

Tools of discovery
por: Lemberger, Thomas
Publicado: (2014)

Single-Nucleotide Variations in Cardiac Arrhythmias: Prospects for Genomics and Proteomics Based Biomarker Discovery and Diagnostics
por: Abunimer, Ayman, et al.
Publicado: (2014)

Platelets in Healthy and Disease States: From Biomarkers Discovery to Drug Targets Identification by Proteomics
por: Gianazza, Erica, et al.
Publicado: (2020)

Proteomics and genomics: perspectives on drug and target discovery
por: Ahn, Natalie G, et al.
Publicado: (2008)

Novel Targets and Mechanisms in Antimicrobial Drug Discovery
por: Tondi, Donatella
Publicado: (2021)

Proteomic profiling of human amnion for preterm birth biomarker discovery
por: Bruschi, Maurizio, et al.
Publicado: (2021)

Proteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
por: Amiri-Dashatan, Nasrin, et al.
Publicado: (2018)

Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Correction: Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin
por: Aune Westergaard Hansen, Gry, et al.
Publicado: (2015)

Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Clinical proteomics: a driving force for cancer therapeutic target discovery and precision medicine
por: Wang, Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j4k2saigjq3qkdhhc7smhpupic